Susquehanna International Group’s Plus Therapeutics PSTV Stock Holding History
Bought
Maintained
Sold
Other funds holding PSTV
LGM
VF
XT
Susquehanna International Group's PSTV Position: Q4 2025 in Review
Susquehanna International Group sold out of Plus Therapeutics (PSTV) in Q4 2025, closing a stake of 2,691 shares — an estimated $46K sold.
Susquehanna International Group first reported a position in PSTV in Q2 2015 and held it in 8 quarters. The position peaked at $3.79M in Q2 2015. 25 funds tracked by Wall St. Rank hold PSTV as of Q4 2025.
- Susquehanna International Group reported no remaining Plus Therapeutics position as of Q4 2025 after selling out during the quarter.
- Susquehanna International Group sold 2,691 Plus Therapeutics shares in Q4 2025, an estimated $46K.
- Susquehanna International Group first reported a position in Plus Therapeutics in Q2 2015 and held it in 8 quarters.
- Susquehanna International Group's Plus Therapeutics position peaked at $3.79M in Q2 2015.
- 25 funds tracked by Wall St. Rank held Plus Therapeutics as of Q4 2025.
Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.